Cargando…

Value of genetic testing in the prevention of coronary heart disease events

BACKGROUND: The health economic evidence about the value and optimal targeting of genetic testing in the prevention of coronary heart disease (CHD) events has remained limited and ambiguous. The objective of this study is to optimize the population-level use and targeting of genetic testing alongsid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hynninen, Yrjänä, Linna, Miika, Vilkkumaa, Eeva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333335/ https://www.ncbi.nlm.nih.gov/pubmed/30645616 http://dx.doi.org/10.1371/journal.pone.0210010

Ejemplares similares

Aspirin as Primary Prevention of Acute Coronary Heart Disease Events
por: Glasser, Stephen P., et al.
Publicado: (2014)

Multimorbidity transitions and the associated healthcare cost among the Finnish adult population during a two-year follow-up
por: Wikström, Katja, et al.
Publicado: (2023)

Common genetic variants do not predict recurrent events in coronary heart disease patients
por: Thompson, P. L., et al.
Publicado: (2022)

Oral Health Outcome Measures: A Feasibility Evaluation
por: Hynninen, Yrjänä, et al.
Publicado: (2023)

Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Coronary Heart Disease (PROSPECTIVE)
por: Yamashita, Shizuya, et al.
Publicado: (2021)

Sex differences in secondary preventive follow-up after coronary heart events
por: Kaldal, Anete, et al.
Publicado: (2023)

Predictive Value of Auricular Diagnosis on Coronary Heart Disease
por: Kwai-Ping Suen, Lorna, et al.
Publicado: (2012)

Statins for the Primary Prevention of Coronary Heart Disease
por: Li, Min, et al.
Publicado: (2019)

Major Bleeding Events Are Stronger Predictors of Long-Term Mortality Than Coronary Events in Secondary Prevention Therapy for Ischaemic Heart Disease
por: Kageyama, Shigetaka, et al.
Publicado: (2020)

Cost–effectiveness of apixaban and warfarin in the prevention of thromboembolic complications among atrial fibrillation patients
por: Hallinen, Taru, et al.
Publicado: (2016)

Revisiting secondary prevention in coronary heart disease
por: Sigamani, Alben, et al.
Publicado: (2022)

How to extend value-based healthcare to population-based healthcare systems? Defining an outcome-based segmentation model for health authority
por: Torkki, Paulus, et al.
Publicado: (2023)

Analysis Of Re-Hospitalizations For Patients With Heart Failure Caused By Coronary Heart Disease: Data Of First Event And Recurrent Event
por: Tian, Jing, et al.
Publicado: (2019)

Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics
por: Gordillo-Marañón, María, et al.
Publicado: (2021)

Prediction of Coronary Heart Disease Events in Blood or Marrow Transplantation Recipients
por: Gangaraju, Radhika, et al.
Publicado: (2023)

The impact of the COVID-19 pandemic on incident cases of chronic diseases in Finland
por: Wikström, Katja, et al.
Publicado: (2022)

Integrated genetic and epigenetic prediction of coronary heart disease in the Framingham Heart Study
por: Dogan, Meeshanthini V., et al.
Publicado: (2018)

Predictive value of LDL/HDL ratio in coronary atherosclerotic heart disease
por: Sun, Ting, et al.
Publicado: (2022)

Coated stents to prevent restenosis in coronary heart disease
por: Gorenoi, Vitali, et al.
Publicado: (2005)

Coronary Heart Disease and Cortical Thickness, Gray Matter and White Matter Lesion Volumes on MRI
por: Vuorinen, Miika, et al.
Publicado: (2014)

Comparison of Genetic Susceptibility to Coronary Heart Disease in the Hungarian Populations: Risk Prediction Models for Coronary Heart Disease
por: Nasr, Nayla, et al.
Publicado: (2023)

Impact of Hepatitis C Seropositivity on the Risk of Coronary Heart Disease Events
por: Pothineni, Naga Venkata, et al.
Publicado: (2014)

Mode of transport, genetic susceptibility, and incidence of coronary heart disease
por: Jiesisibieke, Zhu Liduzi, et al.
Publicado: (2023)

Value of acoustic cardiography in the clinical diagnosis of coronary heart disease
por: Zhang, Fu Wei, et al.
Publicado: (2021)

Mediterranean diet and prevention of coronary heart disease in the elderly
por: Dontas, Anastasios S, et al.
Publicado: (2007)

The current status of primary prevention in coronary heart disease
por: Pater, Cornel
Publicado: (2001)

Prevention of Coronary Heart Disease: Putting Theory into Practice
por: Lewis, Barry, et al.
Publicado: (1991)

Diagnostic value of the cardiopulmonary exercise test in coronary artery disease
por: Li, Ning, et al.
Publicado: (2022)

Cost-effectiveness analysis for a tele-based health coaching program for chronic disease in primary care
por: Oksman, Erja, et al.
Publicado: (2017)

Do we need clinical trials to test the ability of transdermal HRT to prevent coronary heart disease?
por: Crook, David
Publicado: (2001)

Is there a role for genetic risk assessment in the treatment of dyslipidemia in primary and secondary prevention of coronary heart disease?
por: Suwaidi, Jassim Al
Publicado: (2015)

Recent hospitalization for Non-coronary events and use of preventive medications for coronary artery disease: An observational cohort study
por: Bradley, Steven M, et al.
Publicado: (2011)

Genetic Risk Score for Coronary Heart Disease: Review
por: Semaev, Sergey, et al.
Publicado: (2020)

Healthy Hearts – A community-based primary prevention programme to reduce coronary heart disease
por: Richardson, Gill, et al.
Publicado: (2008)

Lipoprotein (a) and coronary heart disease – is there an efficient secondary prevention?
por: Mellwig, Klaus-Peter, et al.
Publicado: (2017)

Identification of 15 novel risk loci for coronary artery disease and genetic risk of recurrent events, atrial fibrillation and heart failure
por: Verweij, Niek, et al.
Publicado: (2017)

Prognostic value of coronary CTA-based classifications for predicting major events without obstructive coronary artery disease
por: Huang, Zengfa, et al.
Publicado: (2023)

Insomnia as a predictor of recurrent cardiovascular events in patients with coronary heart disease
por: Frøjd, Lars Aastebøl, et al.
Publicado: (2022)

Genetic Testing for Early Detection of Individuals at Risk of Coronary Heart Disease and Monitoring Response to Therapy: Challenges and Promises
por: Superko, H. Robert, et al.
Publicado: (2011)

Role of depression in secondary prevention of Chinese coronary heart disease patients receiving percutaneous coronary intervention
por: Feng, Can, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_q3q6js22pgh1c4r4pv7jmr0bvd